PI
MGNX icon

Putnam Investments’s MacroGenics MGNX Stock Holding History

Putnam Investments’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$674K Buy
70,067
+27,984
+66% +$193K ﹤0.01% 891
2023
Q3 		$196K Buy
+42,083
New +$209K ﹤0.01% 1124
2022
Q2 		– Sell
-50,701
Closed -$446K – 1182
2022
Q1 		$446K Buy
50,701
+13,382
+36% +$148K ﹤0.01% 1044
2021
Q4 		$599K Buy
+37,319
New +$702K ﹤0.01% 922

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Putnam Investments's MGNX Position: Q4 2023 in Review

Putnam Investments increased its MacroGenics (MGNX) stake by 66% in Q4 2023, buying an estimated $193K and bringing the position to 70,067 shares worth $674K. The position accounts for ﹤0.01% of the portfolio, ranked #891.

Putnam Investments first reported a position in MGNX in Q4 2021 and has held it in 4 quarters since. 142 funds tracked by Wall St. Rank hold MGNX as of Q4 2023.

  • Putnam Investments held 70,067 shares of MacroGenics worth $674K as of Q4 2023.
  • Putnam Investments bought 27,984 MacroGenics shares in Q4 2023, an estimated $193K.
  • MacroGenics made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #891 holding.
  • Putnam Investments first reported a position in MacroGenics in Q4 2021 and has held it in 4 quarters since.
  • 142 funds tracked by Wall St. Rank held MacroGenics as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.